Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Sector: Medical - Pharmaceuticals
Industry: Medical - Pharmaceuticals
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
USPremier Biomedical, Inc. functions as a company primarily focused on research, actively involved in both the genesis and identification of innovative medical offerings.
The firm specifically directs its efforts toward formulating and disseminating topical pain management solutions that incorporate hemp oil. Established by Mitchell S. Felder on May 10, 2010, the company's central operations are based in Knoxville, Tennessee.
Carl Eller
Marketing & Planning Vice-President
David Caplan
President, Chairman of the Board of Directors, Secretary & Treasurer
Gustavo Carreño
Chief Technology Officer
Employees
4
Country
US
Sector
Healthcare
Website
premierbiomedical.com
Loading congressional disclosures…
US30d Avg
22.35M
60d Avg
14.92M
90d Avg
18.37M
